The mission of I-DireCT is to provide training and carry out breakthrough research on the rapidly expanding and high impact field of cancer immunotherapy in a carefully integrated academic and inter-sectoral programme.
The University Medical Center Groningen (UMCG) | University Hospital Wuerzburg (UKW) | InoCure s.r.o. | KAHR Medical
This project has received funding from the Research and Innovation Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Action (grant agreement No. 813871).
Immunoplex: Screening of auto-immune diseases by multiplex Whispering Gallery Mode (WGM) sensors
Surflay's WhisperSense technology is used and further developed for a reliable and cost-efficient screening of auto-immune diseases in samples.
Diarect AG | Scienion AG
Bundesministerium für Bildung und Forschung (BMBF) (grant agreement No. 031 B498 A)